Prosecution Insights
Last updated: April 19, 2026

ONCOUR PHARMA, INC.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18695943 NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF INFLAMMATION-RELATED BURN INJURIES ARNOLD, ERNST V 1613 Non-Final OA Mar 27, 2024
17922484 NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF CYTOKINE STORM SYNDROME (CSS) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) BELYAVSKYI, MICHAIL A 1644 Final Rejection Oct 31, 2022
17264522 IMMUNE MODIFYING PARTICLES FOR THE TREATMENT OF CANCER FAUST, AMBER KATHLEEN 1643 Final Rejection Jan 29, 2021

Managing ONCOUR PHARMA, INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month